GENEVA: Despite a number of mutations involving the SARS-CoV-2 virus, none of these – including the latest variant in Britain – has had a significant impact on its susceptibility to any of the currently used therapeutics, drugs or vaccines under development, say health experts.
The Xinhua news agency reported World Health Organisation (WHO) chief scientist Dr Soumya Swaminathan as saying the SARS-CoV-2 virus had mutated much more slowly than the influenza virus.The influenza virus requires for its vaccine strains to be reviewed and revised each year based on the circulating strains prevalent that year.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
